Integrating transcriptome and metabolomics analyses of hepatocellular carcinoma to discover novel biomarkers and drug targets. Yang T, Wang SY. Clin Res Hepatol Gastroenterol 2025;49:102546.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang T, Wang SY. Integrating transcriptome and metabolomics analyses of hepatocellular carcinoma to discover novel biomarkers and drug targets. Clin Res Hepatol Gastroenterol 2025;49:102546.
PMID: 39938636